Logo image of CLH

CLEAN HARBORS INC (CLH) Stock Fundamental Analysis

NYSE:CLH - US1844961078 - Common Stock

245.61 USD
+1.29 (+0.53%)
Last: 8/27/2025, 8:04:00 PM
245.61 USD
0 (0%)
After Hours: 8/27/2025, 8:04:00 PM
Fundamental Rating

5

Taking everything into account, CLH scores 5 out of 10 in our fundamental rating. CLH was compared to 84 industry peers in the Commercial Services & Supplies industry. CLH has an average financial health and profitability rating. CLH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CLH was profitable.
CLH had a positive operating cash flow in the past year.
In the past 5 years CLH has always been profitable.
Each year in the past 5 years CLH had a positive operating cash flow.
CLH Yearly Net Income VS EBIT VS OCF VS FCFCLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

With a decent Return On Assets value of 5.17%, CLH is doing good in the industry, outperforming 70.24% of the companies in the same industry.
CLH has a better Return On Equity (14.18%) than 77.38% of its industry peers.
CLH has a Return On Invested Capital of 7.62%. This is in the better half of the industry: CLH outperforms 70.24% of its industry peers.
CLH had an Average Return On Invested Capital over the past 3 years of 8.67%. This is below the industry average of 10.78%.
Industry RankSector Rank
ROA 5.17%
ROE 14.18%
ROIC 7.62%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
CLH Yearly ROA, ROE, ROICCLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

With a decent Profit Margin value of 6.48%, CLH is doing good in the industry, outperforming 73.81% of the companies in the same industry.
In the last couple of years the Profit Margin of CLH has grown nicely.
CLH has a Operating Margin of 10.96%. This is in the better half of the industry: CLH outperforms 73.81% of its industry peers.
CLH's Operating Margin has improved in the last couple of years.
The Gross Margin of CLH (30.76%) is comparable to the rest of the industry.
CLH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.96%
PM (TTM) 6.48%
GM 30.76%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
CLH Yearly Profit, Operating, Gross MarginsCLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLH is creating some value.
CLH has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CLH has been reduced compared to 5 years ago.
Compared to 1 year ago, CLH has a worse debt to assets ratio.
CLH Yearly Shares OutstandingCLH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLH Yearly Total Debt VS Total AssetsCLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CLH has an Altman-Z score of 3.47. This indicates that CLH is financially healthy and has little risk of bankruptcy at the moment.
CLH has a better Altman-Z score (3.47) than 67.86% of its industry peers.
CLH has a debt to FCF ratio of 7.39. This is a slightly negative value and a sign of low solvency as CLH would need 7.39 years to pay back of all of its debts.
The Debt to FCF ratio of CLH (7.39) is better than 63.10% of its industry peers.
A Debt/Equity ratio of 1.02 is on the high side and indicates that CLH has dependencies on debt financing.
CLH has a Debt to Equity ratio of 1.02. This is in the lower half of the industry: CLH underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 7.39
Altman-Z 3.47
ROIC/WACC0.92
WACC8.26%
CLH Yearly LT Debt VS Equity VS FCFCLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 2.45 indicates that CLH has no problem at all paying its short term obligations.
CLH has a Current ratio of 2.45. This is in the better half of the industry: CLH outperforms 78.57% of its industry peers.
CLH has a Quick Ratio of 2.07. This indicates that CLH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.07, CLH belongs to the best of the industry, outperforming 84.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 2.07
CLH Yearly Current Assets VS Current LiabilitesCLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for CLH have decreased by -1.79% in the last year.
Measured over the past years, CLH shows a very strong growth in Earnings Per Share. The EPS has been growing by 31.46% on average per year.
CLH shows a small growth in Revenue. In the last year, the Revenue has grown by 5.49%.
CLH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.54% yearly.
EPS 1Y (TTM)-1.79%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-4.07%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%-0.18%

3.2 Future

The Earnings Per Share is expected to grow by 12.25% on average over the next years. This is quite good.
CLH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.88% yearly.
EPS Next Y2.75%
EPS Next 2Y10.79%
EPS Next 3Y15.54%
EPS Next 5Y12.25%
Revenue Next Year2.71%
Revenue Next 2Y4.08%
Revenue Next 3Y5.5%
Revenue Next 5Y4.88%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLH Yearly Revenue VS EstimatesCLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CLH Yearly EPS VS EstimatesCLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

CLH is valuated quite expensively with a Price/Earnings ratio of 34.50.
CLH's Price/Earnings is on the same level as the industry average.
CLH is valuated rather expensively when we compare the Price/Earnings ratio to 27.14, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 26.97 indicates a quite expensive valuation of CLH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLH is on the same level as its industry peers.
CLH's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.80.
Industry RankSector Rank
PE 34.5
Fwd PE 26.97
CLH Price Earnings VS Forward Price EarningsCLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLH indicates a somewhat cheap valuation: CLH is cheaper than 61.90% of the companies listed in the same industry.
CLH's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 35
EV/EBITDA 13.91
CLH Per share dataCLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLH does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of CLH may justify a higher PE ratio.
CLH's earnings are expected to grow with 15.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)12.52
PEG (5Y)1.1
EPS Next 2Y10.79%
EPS Next 3Y15.54%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEAN HARBORS INC

NYSE:CLH (8/27/2025, 8:04:00 PM)

After market: 245.61 0 (0%)

245.61

+1.29 (+0.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners94%
Inst Owner Change-0.2%
Ins Owners5.55%
Ins Owner Change-4.72%
Market Cap13.17B
Analysts82.67
Price Target270.83 (10.27%)
Short Float %1.98%
Short Ratio2.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.54%
Min EPS beat(2)-2.32%
Max EPS beat(2)1.24%
EPS beat(4)2
Avg EPS beat(4)1.98%
Min EPS beat(4)-3.86%
Max EPS beat(4)12.88%
EPS beat(8)5
Avg EPS beat(8)1.75%
EPS beat(12)9
Avg EPS beat(12)4.09%
EPS beat(16)13
Avg EPS beat(16)10.5%
Revenue beat(2)0
Avg Revenue beat(2)-2.66%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)-1.58%
Revenue beat(4)1
Avg Revenue beat(4)-1.58%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)0.03%
Revenue beat(8)3
Avg Revenue beat(8)-1.3%
Revenue beat(12)6
Avg Revenue beat(12)-0.41%
Revenue beat(16)10
Avg Revenue beat(16)1.55%
PT rev (1m)3.97%
PT rev (3m)5.15%
EPS NQ rev (1m)2.82%
EPS NQ rev (3m)1.78%
EPS NY rev (1m)-0.53%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)-0.75%
Revenue NQ rev (3m)-1.36%
Revenue NY rev (1m)-1.05%
Revenue NY rev (3m)-1.1%
Valuation
Industry RankSector Rank
PE 34.5
Fwd PE 26.97
P/S 2.22
P/FCF 35
P/OCF 17.5
P/B 4.85
P/tB 23.64
EV/EBITDA 13.91
EPS(TTM)7.12
EY2.9%
EPS(NY)9.11
Fwd EY3.71%
FCF(TTM)7.02
FCFY2.86%
OCF(TTM)14.04
OCFY5.72%
SpS110.8
BVpS50.61
TBVpS10.39
PEG (NY)12.52
PEG (5Y)1.1
Profitability
Industry RankSector Rank
ROA 5.17%
ROE 14.18%
ROCE 10.13%
ROIC 7.62%
ROICexc 8.55%
ROICexgc 13.72%
OM 10.96%
PM (TTM) 6.48%
GM 30.76%
FCFM 6.33%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
ROICexc(3y)9.76%
ROICexc(5y)8.32%
ROICexgc(3y)16.3%
ROICexgc(5y)13.8%
ROCE(3y)11.52%
ROCE(5y)9.73%
ROICexcg growth 3Y10.92%
ROICexcg growth 5Y12.41%
ROICexc growth 3Y14.1%
ROICexc growth 5Y9.64%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
F-Score7
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 7.39
Debt/EBITDA 2.55
Cap/Depr 86.82%
Cap/Sales 6.34%
Interest Coverage 4.19
Cash Conversion 69.4%
Profit Quality 97.81%
Current Ratio 2.45
Quick Ratio 2.07
Altman-Z 3.47
F-Score7
WACC8.26%
ROIC/WACC0.92
Cap/Depr(3y)108.74%
Cap/Depr(5y)95.27%
Cap/Sales(3y)7.36%
Cap/Sales(5y)6.97%
Profit Quality(3y)77.75%
Profit Quality(5y)110.67%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.79%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-4.07%
EPS Next Y2.75%
EPS Next 2Y10.79%
EPS Next 3Y15.54%
EPS Next 5Y12.25%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%-0.18%
Revenue Next Year2.71%
Revenue Next 2Y4.08%
Revenue Next 3Y5.5%
Revenue Next 5Y4.88%
EBIT growth 1Y1.33%
EBIT growth 3Y24.78%
EBIT growth 5Y23.92%
EBIT Next Year73.98%
EBIT Next 3Y28.4%
EBIT Next 5Y19.79%
FCF growth 1Y15.34%
FCF growth 3Y3.81%
FCF growth 5Y11.72%
OCF growth 1Y3.15%
OCF growth 3Y12.52%
OCF growth 5Y13.49%